Treatment of Dermacoccus Infections
For Dermacoccus catheter-related bloodstream infections, remove the catheter and treat with vancomycin as first-line systemic therapy, following the same principles used for other less virulent gram-positive organisms like Micrococcus and Bacillus species.
Rationale and Clinical Approach
Dermacoccus is an extremely rare pathogen, with the first reported case of catheter-related bloodstream infection (CRBSI) occurring in 2015 1. Given the paucity of specific data, treatment must be extrapolated from established guidelines for similar organisms.
Catheter Management
Remove the catheter in all cases after ruling out blood culture contamination with multiple positive cultures (at least one from a peripheral vein). The IDSA guidelines specifically recommend catheter removal for CRBSI due to "less virulent microbes that are difficult to eradicate (e.g., Bacillus species, Micrococcus species, or Propionibacteria)" 2. Dermacoccus falls into this same category of skin commensals that can cause persistent infections when associated with foreign bodies.
Antimicrobial Selection
- First-line: Vancomycin - This is the empirical choice for gram-positive CRBSI in healthcare settings, particularly for organisms without established susceptibility patterns 2
- Alternative agents: Consider linezolid or daptomycin based on susceptibility testing if available 2
- Duration: 7-14 days of systemic therapy after catheter removal for uncomplicated cases 2
Key Considerations
Virulence assessment: While genomic analysis of D. barathri identified nine virulence factors and potential biofilm formation capability 1, the clinical significance remains unclear. Treat this as a potentially persistent pathogen requiring source control.
Antibiotic susceptibility: No antibiotic resistance genes were identified in genomic analysis 1, suggesting susceptibility to standard gram-positive agents, but formal susceptibility testing should guide definitive therapy when possible.
When to Extend Therapy
Treat for 4-6 weeks if any of the following occur:
- Persistent bacteremia >72 hours after catheter removal 2
- Evidence of endocarditis on echocardiography
- Suppurative thrombophlebitis
- Metastatic infectious complications
Monitoring
- Obtain follow-up blood cultures 72 hours after initiating therapy 2
- If attempting catheter salvage (not recommended for Dermacoccus), remove catheter if cultures remain positive at 72 hours 2
Critical pitfall: Do not dismiss positive Dermacoccus cultures as contaminants without careful evaluation. Multiple positive cultures, particularly with clinical signs of infection, warrant full treatment as outlined above.